HURA earnings date and last-quarter result: next report 2026-08-13, last quarter miss, P/E -3.65. Updated 2026-07-23.
TuHURA Biosciences (HURA) Research Hub
TuHURA Biosciences (HURA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.04 USD (-6.42%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.65, market cap 0.14B. This hub links to the full technical, earnings and options research available for HURA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.04 USD (-6.42%) |
| 52-week range | 1.71 USD – 2.72 USD |
| Trend regime | Range |
| 14-day RSI | 53.8 (Neutral) |
| Trailing P/E | -3.65 |
| Market cap | 0.14B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for HURA
Covered Call on HURA: how it works, illustrative setup around the real 2.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HURA: how it works, illustrative setup around the real 2.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HURA: how it works, illustrative setup around the real 2.04 USD price, max profit/loss, breakeven and when to use it. Educational.
HURA technical analysis: range, last 2.04 USD, RSI 53.8, 52w range 1.71 USD–2.72 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is HURA in?
TuHURA Biosciences (HURA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is HURA in an uptrend or downtrend?
As of 2026-10-26, HURA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HURA's trailing P/E ratio?
HURA's trailing P/E is -3.65, with a market cap of 0.14B. See the earnings research page for full valuation detail.
When does HURA next report earnings?
HURA is next scheduled to report earnings on 2026-08-13.